# Regenerative Processing Plant, LLC – FDA Inspection, Jun 30, 2023

Source: https://www.keypedia.com/records/fda_inspections/regenerative-processing-plant-llc/8e1ca4f6-1170-4c07-996a-a38ac2fd60b4
Source feed: FDA_Inspections

> FDA inspection 1209340 of Regenerative Processing Plant, LLC, June 30, 2023. Classification: Official Action Indicated (OAI). 30 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1209340
- Company Name: Regenerative Processing Plant, LLC
- Inspection Date: 2023-06-30
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 30
- Enforcement Type: WARNING_LETTER

## Related Documents

- FDA Inspection 1115241 - 2019-12-12
- FDA Inspection 1026965 - 2017-08-14
- FDA Inspection 940246 - 2015-08-31

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/ivan-e-reyes/69bac3eb-f63c-45f0-8420-85a7e06b884a)
- [Company Rep](https://www.keypedia.com/people/samantha-j-pinizzotto/296e8763-39e9-4b6d-9b89-661322d5a53c)
- [FDA Associated Person](https://www.keypedia.com/people/travis-s-bradley/4d7756cb-65fd-4bd6-be24-25710668e6d8)

Company: https://www.keypedia.com/companies/regenerative-processing-plant-llc/9460f9cb-85fa-400b-9e07-36e5b2a73133

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
